Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Endocrinology
Benign Hematology
Questions discussed in this category
When would you treat mild anemia from low testosterone in an older male?
Would you consider testosterone therapy if he is otherwise asymptomatic?
2 Answers available
Is a history of provoked DVT a contraindication to starting testosterone replacement therapy in a middle aged man with symptomatic hypogonadism who is on anti-coagulation?
1 Answer available
How do you monitor risk of erythrocytosis from testosterone use for female to male transgender patients?
1 Answer available
Would you give transdermal hormone replacement therapy to a woman with remote history of provoked pulmonary embolism?
Is patch or gel HRT with ASA prophylaxis a reasonable option after counseling? Or do you add a prophylactic DOAC?
1 Answer available
In a young female with severe osteoporosis due to congenital estrogen deficiency, can estrogen be prescribed if genetic testing for congenital disorders reveals a heterozygous Factor V Leiden mutation?
No prior thrombosis; no family history of thrombosis. As per endocrine, the only useful therapy for the osteoporosis is estrogen.
1 Answer available
Do you treat secondary erythrocytosis caused by SGLT2 inhibitor?
1 Answer available
What recommendations do you have for a transgender female patient with history of prothrombin gene mutation who is interested in starting gender affirming hormone therapy?
The patient has no personal history of VTE, but has positive family history of VTE. Any prophylactic anticoagulation options? How would manage...
1 Answer available
How do you counsel male-to-female transgender patients on the VTE risk of hormonal therapy?
1 Answer available
21129
20409
14321
15755
16563
14292
13903
8711
Papers discussed in this category
BMJ, 2008 May 20
Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.
Circulation,
Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
Post reproductive health, 2022 Dec 27
Hormone replacement therapy in women with history of thrombosis or a thrombophilia.
Related Topics in Endocrinology
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Neuro-Oncology
Genitourinary Cancers
Melanoma/Skin Cancer